19 Jan 2018 | 2:01 AM
 

Ajanta Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 532331 | NSE Symbol: AJANTPHARM
1,531.80
1.11
(0.08 %)
18 Jan 2018 | 04:01 PM
Change company
  • Open (Rs)
    1,538.20
  • Prev. close (Rs.)
    1,530.70
  • High (Rs.)
    1,562.00
  • Low (Rs.)
    1,525.00
  • 52W H (Rs.)
    1,870.00
  • 52W L (Rs.)
    1,106.00
  • Volume
    20433
  • MCap (Rs in Cr.)
    13,482.14
1539.95
6.45
(0.42 %)
  • Open (Rs)
    1,540.00
  • High (Rs)
    1,566.90
  • Low (Rs)
    1,521.75
  • Prev. close(Rs)
    1,533.50
  • Contracts Tra.
    10,21,000
  • Turnover (Cr.)
    158
  • Open Interest
    9,95,500
  • Open Int. chg
    9,93,900.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
57.59
Operating Margin (%)
34.42
Gross Profit Margin (%)
31.36
Net Profit Margin (%)
25.32
Total Debt/Equity
0.00
Dividend payout Ratio (Net Profit)
25.43
Earning Retention Ratio
74.57

News

21 Nov 2017 - 16:14:00-Ajanta Pharma said that it has launched Clonidine Hydrochloride Extended Release Tablets in the US M...
04 Sep 2017 - 11:03:00-Leading pharma major Ajanta Pharma Limited has said that it has received final approval for Entacapo...
04 Sep 2017 - 11:03:00-Leading pharma major Ajanta Pharma Limited has said that it has received final approval for Entacapo...
31 Aug 2017 - 11:01:00-Ajanta Pharma Limited has said that it has launched Eletriptan Hydrobromide Tablets in the US market...

Announcements

18-Jan-2018
Ajanta Pharma Lt - Shareholding for the Period Ended December 31 2017
15-Jan-2018
Ajanta Pharma Lt - Board Meeting On Thursday 25Th January 2017.
15-Jan-2018
Ajanta Pharma Lt - Closure of Trading Window
15-Jan-2018
Ajanta Pharma Lt - Trading Window
12-Jan-2018
Ajanta Pharma Lt - Statement Of Investors` Complaint For The Quarter Ended 31St December 2017

Religare Research

18 Jan 2018 | 10:09 AM
The rupee ended at 63.88 to a dollar from 64.03 at the previous close. It rose 0.23% intraday, marki...
18 Jan 2018 | 10:00 AM
Highlights: • Agri markets kept trading with high volatility as the uptrend got limited from i...
18 Jan 2018 | 09:41 AM
• Gold prices slipped as dollar recovered from 3-yr low • Oil little changed ahead of U.S. weekly cr...
18 Jan 2018 | 07:00 AM
The underlying sentiments continue to remain positive for the Indian markets. However, with indices ...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
8,84,202 132.61 27.53 -0.20
8,84,202 132.61 27.18 -0.20
8,84,202 132.61 28.20 -0.20
8,84,202 132.61 28.55 -0.20
2,50,161 37.52 26.95 -1.28

Shareholding Pattern

       
Promotors70.70%
Mutual Funds/UTI5.09%
FI/Banks0.35%
Insurance0.35%
FII12.19%
Government0.00%
Others1.64%

Peer Group

Company Intraday Graph
 Abbott India Ltd.
5,400.00(-1.14)
3280
 Sanofi India Ltd.
4,665.00(-0.19)
3325
 Piramal Enterprises Ltd.
2,769.00(-2.57)
3356
 GlaxoSmithKline Pharmaceuticals Ltd.
2,472.95(-0.12)
3317

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Ajanta Pharma Ltd.92.05338.1068.95
NIFTY(S&P CNX)428.25606.15989.85
BSE SENSEX1,658.612,675.943,549.30
BSE 500598.051,037.821,677.16

Corporate Details

Key Personal
Madhusudan B Agrawal
Vice Chairman
Mannalal B Agrawal
Chairman
Purushottam B Agrawal
Vice Chairman
Key Address
Registered Office
Ajanta House Charkop Kandivli (West),Mumbai,Maharashtra

Tel:022-66061000, Fax:022-66061200 66061300

investorgrievance@ajantapharma.com
http://www.ajantapharma.com
Registrar Office
Link Intime India Pvt. Ltd.
Add. :C 101 247 Park ? L.B.S. Marg Vikhroli (West)